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Abstract
Polycomb proteins play an essential role in maintaining the repression of developmental genes in self-renewing embryonic
stem cells. The exact mechanism allowing the derepression of polycomb target genes during cell differentiation remains
unclear. Our project aimed to identify Cbx8 binding sites in differentiating mouse embryonic stem cells. Therefore, we used
a genome-wide chromatin immunoprecipitation of endogenous Cbx8 coupled to direct massive parallel sequencing (ChIP-
Seq). Our analysis identified 171 high confidence peaks. By crossing our data with previously published microarray analysis,
we show that several differentiation genes transiently recruit Cbx8 during their early activation. Depletion of Cbx8 partially
impairs the transcriptional activation of these genes. Both interaction analysis, as well as chromatin immunoprecipitation
experiments support the idea that activating Cbx8 acts in the context of an intact PRC1 complex. Prolonged gene activation
results in eviction of PRC1 despite persisting H3K27me3 and H2A ubiquitination. The composition of PRC1 is highly modular
and changes when embryonic stem cells commit to differentiation. We further demonstrate that the exchange of Cbx7 for
Cbx8 is required for the effective activation of differentiation genes. Taken together, our results establish a function for a
Cbx8-containing complex in facilitating the transition from a Polycomb-repressed chromatin state to an active state. As this
affects several key regulatory differentiation genes this mechanism is likely to contribute to the robust execution of
differentiation programs.
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Introduction
First identified in Drosophila, the polycomb group of proteins
share conserved domains and play an important role in
coordinated gene repression during vertebrate and invertebrate
development [1]. The prevailing view is that PRC2 and PRC1 act
in a sequential manner. The association of the three proteins Eed,
Suz12 and Ezh2 or Ezh1 leads to the formation of the core PRC2
complex. Ezh1 and Ezh2 are histone methyl transferases that
mediate the addition of up to three methyl groups to lysine 27 of
histone H3 (H3K27me1–3). The trimethylated mark is recognized
by PRC1 complexes that further mediate ubiquitination of H2A
and gene repression [2–4]. More recently, it has been shown that
PRC1 can also be recruited to chromatin in the absence of a
functional PRC2 complex [5–8].
In contrast to PRC2, the composition of PRC1 is highly
modular and much more variable. The ubiquitin ligase that
provides the catalytic activity to the PRC1 complex can be either
Ring1a or Ring1b. The complex additionally includes one of six
Pcgf proteins; one of three orthologs of polyhomeiotic and five
mutually exclusive Cbx proteins can occupy the position of the
Drosophila Polycomb protein. Cbx proteins differ in some of their
domains suggesting that they could convey different functional and
regulatory properties to PRC1 [9]. In addition a variant complex
in which RYBP replaces Cbx proteins has been shown to mediate
repression independent of the methylation status of H3K27 [7].
Mouse embryonic stem (ES) cells are characterized by their
ability to self-renew and their potential to differentiate into any of
the three germ layers. PRC maintain the pluripotency of the cells
by maintaining the developmental regulators repressed [10–12].
On differentiation ES cells acquire cell-type specific gene
expression patterns that strongly depend on the genome-wide
redistribution of the Polycomb proteins [12].
Activation of tissue specific genes correlates with the displace-
ment of Polycomb proteins and a decrease of the H3K27me3
mark during retinoic acid induced neuronal differentiation [13].
However, it has been recently shown that Polycomb proteins can
also be recruited to activated genes to attenuate the retinoic acid
associated transcriptional activation of specific genes [14]. The
important function of Polycomb complexes in the epigenetic
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changes induced by retinoic acid in mouse embryonic stem cells
has been recently reviewed by Gudas [15].
The composition of the PRC1 complex changes during the
differentiation of ES cells. Cbx7 is the primarily expressed
Polycomb ortholog in ES cells but it is quickly downregulated
during differentiation while Cbx2, Cbx4 and Cbx8 are induced
[16,17]. These studies showed that the integrity of Cbx7 was
required for stable ES cell maintenance, while Cbx2 and Cbx4
were required for balanced lineage specification. It is worth noting
that similar results have been obtained for hematopoietic stem cells
[18].
However, some important questions about Polycomb proteins
remain unanswered. Despite their overt relevance for ES cell
differentiation, it is poorly understood how Polycomb repressed
states are established and resolved. How PRCs are initially
recruited to target genes is a matter of continuous debate
(discussed in [1]). Similarly it is unclear how the transition from
a PRC repressed state to an active state is achieved. How changes
in PRC composition relate to these transitions has not been
investigated. Here, we analyzed the genome wide recruitment of
Cbx8 in ES cells induced to differentiate. We provide compelling
evidence suggesting that Cbx8 is part of a transitory PRC1
complex facilitating the activation of Cbx7-PRC1-repressed genes
during the commitment to differentiation.
Results
During ES cell differentiation Cbx8 is recruited to
activated developmental genes
We used retinoic acid (RA) to induce mouse E14 ES cells to
start differentiating towards the neuronal lineage. We confirmed
previous results [16,17] showing that Cbx8 was virtually absent in
self-renewing ES cells but potently induced on protein and RNA
levels after three days of RA-induced differentiation (Fig. 1A and
S1A Figure). To assess the genome wide distribution of Cbx8 in
differentiating ES cells, we enriched Cbx8-bound chromatin by
chromatin immunoprecipitation (ChIP) using an antibody gener-
ated against the unique part of the protein (S1B-G Figure) and
analyzed the co-precipitated DNA by direct massive parallel
sequencing (ChIP-seq). Taking advantage of the fact that Cbx8 is
virtually absent in untreated, self-renewing ES cells (Fig. 1A), we
decided to use both IgG as well as Cbx8 ChIPs from untreated
cells as negative controls. We were able to uniquely map 9–16
million reads per sample (S2A Figure). For our further analysis we
used a set of high confidence binding sites that were identified by
the overlap of peaks that were called by MACS comparing Cbx8
ChIP from RA-treated ES cells to IgG and those called comparing
Cbx8 ChIP from RA-treated ES cells to the antibody-specific
background ChIPed from untreated cells (S2B Figure). By this
method we were able to identify a subset of 171 peaks
corresponding to Cbx8 binding sites of high confidence (S1
Table). Peaks were annotated to the nearest gene if the center of
the peak was inside a window flanking the transcribed region by 3
kb. Plotting the average read coverage on genes with annotated
Cbx8 indicated that Cbx8 tends to accumulate on gene bodies but
also to spread into upstream and downstream regions (Fig. 1C).
Using this annotation we found that the large majority (141/171)
of identified peaks are associated to annotated genes (Fig. 1D). We
performed a microarray analysis comparing self renewing
untreated ES cells and differentiating cells after 3 days of RA
treatment and crossed the data with our ChIP-seq to identify
possible transcriptional changes on Cbx8 target genes. Taking into
consideration the established function of Polycomb proteins in
gene repression, we expected target genes to either not change
because they are maintained in a repressed state or to be
downregulated. We could extract data for 121 of the 141 gene-
associated peaks. We found that about one third of these Cbx8
binding sites (53 peaks) annotated to genes that displayed a more
than 1.5-fold change in gene expression. To our surprise the large
majority of these genes (44/53) was not down- but upregulated
(Fig. 1E). Most of these upregulated genes were repressed in
untreated cells as indicated by very low average probe intensities
(Fig. 1F). Though a previous report has already shown that Cbx8
can be found on a handful of activated genes in differentiating cells
[19], our data suggested that this could actually be true for a
substantial fraction of Cbx8 target genes. In order to confirm this,
we selected a panel of target and control genes and simultaneously
analyzed Cbx8 recruitment and the corresponding mRNA levels.
We were able to confirm differentiation-induced recruitment of
Cbx8 on all target genes tested while control genes were negative
(Fig. 2A). Target genes included many important key differenti-
ation genes such as Sox9, Gata6 and Nkx6-1 whose expression was
potently induced (Fig. 2B). In order to exclude the possibility that
Cbx8 binding and active transcription might occur on different
and exclusive alleles within the cell population, we analyzed the
co-occurrence of Cbx8 and H3K36me3, which is a mark of active
transcription [20], by coupled ChIP in differentiating ES cells
treated for three days with RA. First, we have analyzed five Cbx8
target genes and four non-target genes that included Oct4, Nanog,
Gapdh and Rpo. Despite the fact that Nanog is downregulated
after three days of RA treatment (Fig. 2B) it still retained some
H3K36me3 that was in a similar range as on the activated gene
Sox9 or the constitutively active gene Gapdh (Fig. 2C, left panel)
suggesting that removal of the active mark H3K36me3 follows a
slower dynamic than the actual gene repression. Taking advantage
of the fact that with Gapdh, Nanog, and Sox9 we had identified
target and non-target genes of Cbx8 with comparable H3K36me3
levels, we have used anti-Cbx8 antibody-enriched chromatin as
input material for a secondary ChIP with IgG and anti-
H3K36me3 antibody. As shown in the right panel of Fig. 2C,
we found a clear enrichment of H3K36me3 over IgG on Sox9 and
on the other Cbx8 target genes but not on non-target genes such
as Gapdh or Nanog. As chromatin ranging in size between 300–
500 bps has been used for these experiments H3K36me3 and
binding of Cbx8 could be occurring on different H3 tails on the
Author Summary
Cell fate transitions have long been known to be
accompanied by alterations in chromatin structure. But
only during the last few years has it become clear that
chromatin modifications form the molecular basis of an
epigenetic memory that defines cell identity. The Poly-
comb Group Proteins (PcGs) form two major protein
complexes known as polycomb repressive complexes 1
and 2 (PRC1 and PRC2). Their function is essential for the
maintenance of transcriptional repression during embryo-
genesis through the methylation of the lysine 27 on
histone H3 and the subsequent ubiquitination of histone
H2A. The chromobox homolog 8, Cbx8, which is part of
the PRC1 complex, is therefore generally defined as a
repressor of gene transcription. The genome wide profiling
of Cbx8 during the early steps of mouse embryonic stem
(mES) cells differentiation provided us with surprising
results involving Cbx8 in gene activation. Our results point
out that Cbx8 is part of a PRC1 complex involved in the
transition from a Polycomb repressed state to an active
state.
Cbx8 Facilitates Gene Activation
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same or even neighboring nucleosomes. The observation that
Cbx8 can be simultaneously detected on the same locus provides
further support to the idea that Cbx8 is recruited to genes that
become actively transcribed.
Cbx8 facilitates gene activation
To study the functional importance of Cbx8 for the activation of
differentiation genes, we used lentiviral vectors expressing two
different short hairpin RNAs (shRNA) directed specifically against
the Cbx8 transcript. After selection stably transduced cells were
used for the study. Both shRNAs efficiently repressed the
expression of Cbx8 on both the mRNA and protein levels in ES
cells treated with RA (Fig. 3A,B). The activation of upregulated
Cbx8 target genes was significantly decreased in cells depleted for
Cbx8 (Fig. 3C). Among the Cbx8-sensitive genes were several
pivotal regulators of differentiation processes such as Sox9 and
Nkx6-1, that have been shown to be important transcription
factors required for normal brain development [21,22]. The
reduction of Cbx8 occupancy was similarly efficient on up- as well
as downregulated genes (Fig. 3D), however, the reduction in Cbx8
levels didn’t affect the repression of its target genes Prdm14 and
Otx2 (Fig. 3C). Importantly, the non-target genes Oct4 and
Nanog, which encode the regulators of pluripotency, were
similarly repressed in Cbx8 deficient and control cells (Fig. 3C,D).
Plotting enriched gene ontologies according to their similarity in a
semantic space illustrates a clear overrepresentation of both
transcriptional and differentiation regulators (Fig. 4A), which are
the classical categories of Polycomb target genes in self-renewing
ES cells [12]. Gene ontologies related to neuronal development
were preferentially enriched in the subgroup of activated Cbx8
Fig. 1. Cbx8 is upregulated and recruited to activated genes during ES cell differentiation. (A) Lysates from E14 mouse embryonic stem
(mES) cells treated or not with 1 mM retinoic acid (RA) during 3 days were analyzed by Western blotting using anti-Cbx8 and anti-Cbx7 antibodies.
Histone H3 was used as loading control. (B) ChIP-seq profiles of IgG and Cbx8 of selected genes in ES cells treated with RA for 3 days or left untreated
are shown using the UCSC Genome Browser. (C) Normalized read distribution of genes with associated Cbx8 peaks in ES cells treated with RA for
three days. Please note that average read distribution on gene bodies is plotted after normalization for the size of transcribed regions, while regions
upstream of the transcription start site (TSS) and downstream of the transcription end site (TES) are plotted linear. (D) The large majority of Cbx8
peaks are associated with genes considering a window of the transcribed region 63 kb. (E) For 121 of the 141 gene-associated peaks we extracted
transcriptional information from whole genome expression microarrays of ES cells treated with RA for 3 days and untreated control cells. The
proportion of genes with upregulated, downregulated or unchanged expression using a 1.5-fold change as cut-off is plotted in a pie chart and
absolute numbers are indicated in brackets. (F) Average probe intensities corresponding to the up- and downregulated Cbx8-target genes indicated
in E are shown in a boxplot for untreated and RA-treated cells. Note that probe intensities from 6-7 correspond to background levels. All data plotted
in D–F is detailed in S1 Table.
doi:10.1371/journal.pgen.1004851.g001
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genes but not those target genes that did not show any change in
gene expression (S3A Figure). Downregulated genes were not
sufficient in number to yield a result in gene ontology analysis. We
compared our genome wide Cbx8 binding profile in differentiating
ES cells with published ChIP-seq data obtained from self-renewing
ES cells [17]. The binding of Cbx8 in RA-treated differentiating
ES cells mirrors the binding of PRC1 proteins Ring1b and Cbx7
within H3K27me3 domains in untreated self-renewing ES cells
(Fig. 4B). As shown in Fig. 4C, this holds true for the vast majority
of Cbx8 binding sites in RA-treated ES cells as 133/171
overlapped with sites bound by Cbx7 in self-renewing ES cells.
Similar overlaps were observed with Ring1b and H3K27me3 (S3B
Figure).
Cbx8 acts as part of a PRC1 complex
The unexpected link between Cbx8 recruitment and gene
activation prompted us to analyze whether Cbx8 acted alone, as
part of a PRC1 or part of a different complex. First we compared
the dynamics in occupancy of Cbx8 and Ring1b, which is the least
variant component of PRC1. As already suggested by the ChIP-
seq data (Fig. 4B), Ring1b was strongly enriched on target genes in
self-renewing ES cells. While the recruitment of Cbx8 initially
increased and peaked after three days of retinoic acid induction,
the binding of Ring1b decreased progressively reaching back-
ground levels at day five of differentiation (Fig. 5A). At day five of
retinoic acid induced differentiation, the Cbx8 occupancy dropped
to very low levels similar to Ring1b. In contrast, H2A
ubiquitination, mark set by Ring1b [23], persisted over the entire
time course (Fig. 5A). In order to understand whether Cbx8 and
Ring1b are acting together, we decided to identify the proteins
that bind Cbx8 during ES cell differentiation. Therefore, we
generated ES cells stably expressing epitope-tagged Cbx8
(Fig. 5B). Exogenous Cbx8 expressed in untreated ES cells bound
to the same target genes as endogenous Cbx8 in RA-treated ES
cells suggesting that the epitope does not affect its function (S4A
Figure). We harvested cells at day three of differentiation which
corresponds to the time point with maximal recruitment of
endogenous Cbx8 to target genes (Fig. 5A). Cbx8 and interacting
proteins were enriched by affinity purification, analyzed by mass
spectrometry and significantly enriched proteins were ranked
according to their abundance (S2 Table). After the bait protein
Cbx8, the top five ranked proteins were the PRC1 subunits
Ring1a/b, Phc2 and the Pcgf proteins Mel18 and Bmi1. Three
additional PRC1 subunits were found in lower abundance
(Fig.5B). Next, we tested whether Ring1b and H2A ubiquitination
co-occur with Cbx8 on genes. Therefore, we have used anti-Cbx8
Fig. 2. Cbx8 binding coincides with gene activation. (A) The occupancy of Cbx8 on genes was analyzed by ChIP in untreated ES cells and
differentiating cells treated with RA for 3 days. Data is plotted as percentage of ChIP-enriched DNA in respect to DNA from input material. Error bars
denote s.d., and n= 3. (B) qRT-PCR analysis of mRNA levels in the same cells as A. Levels in untreated cells have been set to one. Error bars denote s.d.,
and n= 3. (C) ChIP and ReChIP analyses performed with differentiating ES cells treated with RA for three days are shown. Anti-H3K36me3 and control
IgG antibody were used in a primary ChIP (left panel) or in a secondary ChIP performed on material enriched in a primary ChIP with anti-Cbx8
antibody (right panel). ReChIP data is plotted relative to IgG. Error bars denote s.d., n = 3.
doi:10.1371/journal.pgen.1004851.g002
Fig. 3. Knockdown of Cbx8 reduces transcription of activated target genes. (A) The mRNA levels of Cbx8 in control cells (sh Scr) and after
shRNA-mediated knockdown of Cbx8 using lentiviral transduction of two independent hairpins (#1 and #2) were analyzed by qRT-PCR before and
after treatment with RA. Error bars denote s.d., and n= 3. (B) Western blot analysis of Cbx8 in RA-treated ES cells. Histone H3 was used as loading
control. (C) Transcript expression levels of genes in cells expressing Cbx8-specific shRNAs or control shRNA (indicated by minus) were analyzed. Color
code of target genes is according to Figs. 1F and 2B. For each gene, values are plotted relatively to control treated with RA. Error bars denote s.d.;
n = 3; *, p,0.05 (comparing to RA-treated control). (D) The occupancy of Cbx8 on the same genes was analyzed by ChIP. Error bars denote s.d., and
n= 3.
doi:10.1371/journal.pgen.1004851.g003
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antibody-enriched chromatin as input material for a secondary
ChIP with IgG, anti-Ring1b and anti-ubiquitinated H2A
antibody. As shown in Fig. 5C we could detect co-enrichment
on the target genes Sox9, Nkx6-1, Lhx2 and Gata2 but not on the
non-target genes Oct4, Rpo or Gapdh. Taken together, these
results suggested that Cbx8 acts as part of a PRC1 complex.
To further support this, we have analyzed the occupancy of
Cbx8 target genes by Ring1b, Cbx7 and H2A ubiquitination in
RA-treated cells after Cbx8 knockdown. The resulting reduction
of Cbx8 occupancy (Fig. 3D) correlated with a small but consistent
reduction of Ring1b on several Cbx8 target genes without
affecting non-target genes (Fig. 6). Notably, global Ring1b protein
levels were not affected (S4B Figure). However, we observed an
increased incorporation of Cbx7 that could partially compensate
for Cbx8 loss (Fig. 6). This was not the consequence of an
upregulation of Cbx7 expression as knockdown of Cbx8 did not
affect the mRNA levels of Cbx7 or other Cbx proteins (S4C
Figure). Moreover we found that Cbx8 loss did not affect the levels
of H2A ubiquitination on its target genes (Fig. 6). In order to
address the question whether Cbx8-containing PRC1 on activated
genes is repressive or activating, we stably interfered with the
expression of Ring1b, the least variant component of PRC1.
When analyzing Ring1b knockdown cell after 3 days of RA
treatment we did not observe any compensation by Ring1a but a
slight increase in Cbx8 mRNA (S4D Figure). Under these
conditions the Cbx8 target gene Gata2 was further upregulated
while other target genes such as Nkx6-1 and Sox17 were less
activated (S4D Figure). These results are difficult to interpret as
Fig. 4. Cbx8 target genes are PRC1 target genes in self-renewing ES cells. (A) Cbx8-enriched GO categories are visualized using REVIGO [48]
which allows to cluster GO according to their similarity in a semantic space. Only GO categories with an adjusted P-value of 0.001 or less are shown
using ‘‘medium’’ for the allowed semantic similarity. (B) ChIP-seq profiles of H3K27me3, Ring1b, Cbx7 and Cbx8 in ES cells in self-renewing conditions
and of Cbx8 and IgG in RA-treated ES cells are shown using the UCSC genome browser. (C) Venn diagram showing the overlap of Cbx8 target genes
in RA-treated cells with those of Cbx7 in untreated, self-renewing ES cells.
doi:10.1371/journal.pgen.1004851.g004
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Fig. 5. Cbx8 is part of a PRC1 complex and transiently bound to activated genes. (A) Time course of RA-induced differentiation of ES cells.
mRNA levels and occupancy by Cbx8, Ring1b and H2A K117 mono-ubiquitination (H2Aub1) were analyzed by qRT-PCR and ChIP, respectively. Error
bars denote s.d.; n$3. (B) FLAG-affinity purifications from mock and FLAG epitope-tagged (e)-Cbx8 expressing cells treated with RA for 3 days,
analyzed by LC-MS/MS. Enriched proteins were ranked according to abundance (see also S2 Table). Relative abundance to bait is indicated with +, 1–
10%; ++, 10–30%; +++, 30–50%; and ++++, .50%. (C) ReChIPs using anti-Ring1b, anti-H2Aub1 antibodies and IgG as control were performed on
material enriched in a primary ChIP with anti-Cbx8 antibody. Data is plotted relative to IgG. Error bars denote the variation of the mean of two
independent experiments.
doi:10.1371/journal.pgen.1004851.g005
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knockdown of Ring1b interferes with all PRC1 complexes present
prior and after RA treatment.
Cbx8-containing PRC1 binds to persisting H3K27me3
We then focused our attention on the mechanism that recruits
Cbx8 to its target genes. An obvious possibility is that it binds
directly to H3K27me3. Although activated Cbx8 target genes
progressively reduced their H3K27me3 levels, in contrast to
Ring1b, this reduction occurred only very slowly and even after
five days of differentiation genes still retained half-maximal or even
higher levels of H3K27me3 (Fig. 7A). Depletion of Cbx8 did not
affect the amount of H3K27me3 detectable 3 days after RA
treatment (Fig. 7B). We then analyzed by ChIP-ReChIP if Cbx8
and H3K27me3 co-occur on target genes in ES cells treated for 3
days with RA. Indeed, we found that Cbx8 and H3K27me3 co-
existed on Cbx8 target genes (Fig. 7C). This suggests that also in
the context of gene activation the interaction of Cbx8 with
H3K27me3 is the most likely mechanism of recruitment to
chromatin.
In addition to H3K27me3, at day 3 of RA treatment we also
detected some acetylation of the same residue on Cbx8 target
genes (S5B Figure). This H3K27ac was of low level when
compared to an enhancer that was previously described to be
marked by H3K27ac in ES cells (S5A Figure) [24]. Curiously,
knockdown of Cbx8 lead to a modest but significant decrease of
H3K27ac (S5B Figure). The presence of these two mutually
Fig. 6. Loss of Cbx8 is partially compensated by Cbx7. The presence of Ring1b, Cbx7 and H2A ubiquitination (H2Aub1) in control cells (sh Scr)
and after shRNA-mediated knockdown of Cbx8 using two independent hairpins was analyzed by ChIP after 3 days RA treatment. IgG was used as
background control and is indicated by minus signs. For each Cbx8 target gene values are plotted relatively to control cells. Enrichments on-target
genes are plotted relative to the average enrichment on all six target genes in control cells. Error bars denote s.d.; n = 3; *, p,0.05. (compared to
control cells).
doi:10.1371/journal.pgen.1004851.g006
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Fig. 7. Cbx8 binds to persisting K27 methylation during differentiation. (A) Trimethylation of lysine 27 of Histone H3 was analyzed by ChIP
during a time course of RA-induced differentiation of ES cells. Control ChIPs with IgG are shown in the top panel on the same scale. Error bars denote
s.d.; n$3; n.d. = not done. (B) ChIP of H3K27me3 (+) and IgG (-). For each Cbx8 target gene values are plotted relatively to control cells. Enrichments
on-target genes are plotted relative to the average enrichment on all six target genes in control cells. Error bars denote s.d.; n = 3. (C) ReChIPs using
anti-K27me3 antibody and IgG as control were performed on material enriched in a primary ChIP with anti-Cbx8 antibody. Data is plotted relative to
IgG. Error bars denote the variation of the mean of two independent experiments.
doi:10.1371/journal.pgen.1004851.g007
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exclusive H3K27 marks provided us with a valuable tool to
interrogate the preferential binding of Cbx8. First we titrated both
antibodies to reach similar enrichment in ChIP assays (S5C
Figure). Then we used the enriched material to perform a
sequential ChIP for Cbx8. As shown in S5C Figure, Cbx8
preferentially bound K27me3-marked chromatin.
Cbx8 is required for efficient gene activation but not
sufficient to induce it
Cbx7 and Cbx8 are expressed in an almost mutually exclusive
manner in self-renewing and differentiating ES cells, respectively
[16,17]. To further gain additional insight into the functional
relevance of the switch from Cbx7 to Cbx8 on target genes, we
generated mouse embryonic stem cells that stably express
exogenous Cbx8 and analyzed them in self-renewing conditions
while cells expressing exogenous Cbx7 were analyzed in differen-
tiating cells after 3 days of retinoic acid induction (Fig. 8A). When
expressed in self-renewing cells, exogenous Cbx8 was able to
efficiently outcompete Cbx7 for its target genes (Fig. 8B). The
enforced recruitment of exogenous Cbx8 achieved under these
conditions was two-to-three-fold higher than that observed in
differentiating cells for the endogenous protein (Fig. 8B), although,
this did not affect the low expression level of these genes (Fig. 8C).
In the converse experiment during differentiation, Cbx7 overex-
pression significantly reduced the activation of Cbx8 target genes
(Fig. 8C). Although enrichment of overexpressed Cbx7 on target
genes did not reach the levels of the endogenous protein in self-
renewing cells, it resulted in an efficient displacement of Cbx8
(Fig. 8D).
Discussion
Cbx8 is part of a transition PRC1 acting during initial
gene activation
Taken together our results support a model in which PRC1
containing Cbx8 replace PRC1 containing Cbx7 on developmen-
tal genes, which facilitates the transition from a repressed
chromatin state to gene activation during early ES cell differen-
tiation (Fig. 8E). Prolonged gene activation results in eviction of
PRC1 complexes despite some persisting H3K27me3 and H2A
ubiquitination. This mechanism affects several key regulatory
genes and thus probably contributes to a robust execution of
differentiation programs.
Our data supports the idea that Cbx8 acts in the context of an
intact PRC1 complex. Initially, we considered also two other
possibilities: Cbx8 could act as monomer competing with
repressive PRC1 complexes for H3K27me3 binding sites, or
Cbx8 acts in complex with non-polycomb proteins that are
activating. Indeed, in leukemia cells Cbx8 has already been
described as a component of activating complexes containing
Tip60 and MLL-AF9 [25]. However, performing mass spectro-
metric analysis of affinity purified Cbx8-complexes from differen-
tiating ES cells we could not detect any of these proteins, but
rather found other PRC1-components acting as main binding
proteins (Fig. 5B). Moreover, we have shown that Ring1b was
enriched on Cbx8 immunoprecipitated chromatin compared to
IgG (Fig. 5C) and that the knockdown of Cbx8 resulted in a small
but detectable reduction of Ring1b occupancy on genes (Fig. 6).
Since we would have expected the opposite if Cbx8 acted as a
monomer on target genes, this observation taken together with our
co-immunoprecipitation data strongly argued for Cbx8 to be
functioning in the context of a PRC1 complex.
Replacement of Cbx7-containing PRC1 for a Cbx8-
containing complex
One fundamental question is how a Cbx8-containing PRC1 is
able to contribute to gene activation. A plausible explanation
could be that Cbx8-containing PRC1 is simply less repressive than
the PRC1 containing Cbx7 that it replaces. This prompted us to
test whether Cbx8 has an influence on PRC1 activity. When
monitoring the ubiquitination of H2A, we found that its levels on
Cbx8 target genes neither decreased during the first five days of
differentiation nor changed on depletion of Cbx8 (Figs. 5A, 6). It
has been shown that Ring1b mediates chromatin compaction and
gene repression independently of its catalytic activity [26]. In that
regard, it would be interesting to test whether changes in PRC1
composition affects its capacity to compact chromatin. If Cbx7-
containing PRC1 complexes induced a higher degree of chromatin
compaction, this could possibly be relaxed on replacement by
Cbx8. Knockdown of Ring1b itself let to the further activation of a
Cbx8 target gene but to a reduction in the activation of several
other Cbx8 target (S4D Figure). It is intriguing to speculate that
the outcome could depend on the ratio of Cbx7 and Cbx8-
containing PRC1 complexes present at the time point of analysis
and the gene-specific kinetics of activation. However, the
interpretation of such data is complicated by the large number
of binding sites of Ring1b as its other target genes could exert
indirect effects and the fact that Ring1b occurs in both PRC1 and
non-PRC1 complexes [27]. Finally, of course we cannot exclude
the possibility that Cbx8-containing PRC1 complexes are able to
recruit activating proteins in a very transient way, which would not
be captured by our purification and mass spectrometric analysis.
Dynamic gene regulation and slower turnover of
chromatin marks
Both the replacement of Cbx7-containing PRC1 for Cbx8
loaded complexes and the complete eviction of all PRC1 after
prolonged activation occurs in the context of persisting
H3K27me3 and H2A ubiquitination. This reiterates that these
marks have a slow turnover and are not necessary a reflection of
gene activity or repression, in particular during dynamic cell fate
transitions. On Cbx8 target genes we could detect low levels of
H3K27ac that were further reduced mildly but significantly in cells
depleted for Cbx8 (S5B Figure). Whether Cbx8-dependent
H3K27ac is a cause or consequence of enhanced transcription is
unclear. H3K27ac could positively affect chromatin accessibility
for transcription-supporting factors. However it is more likely that
the observed low level of H3K27ac is a collateral consequence of
an increased concentration of histone acetylases travelling with
Polymerase II.
PRC1 modularity during ES cell differentiation
The modularity of PRC1 is illustrated by the fact that there are
180 theoretical combinations for assembling the different PRC
subunits. The real number of different PRC1 complexes existing
under different physiological conditions is likely to be much lower
due to mutually exclusive expression patterns and preferential
binding between subunits. The systematic proteomic and epige-
nomic analysis of all six PCGF proteins shed some initial light on
the different compositions and genomic distributions of PRC1
complexes [28]. On the one hand proteomic studies allowed the
identification of new PRC1 components such as RYBP and YAF2,
while on the other hand they increased doubts about the
genuineness of subunits that had previously been considered to
be canonical; such as Cbx6. A major challenge for the field is to
understand how the modularity of PRC1 is regulated and how it
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contributes to cellular functions. Self-renewing ES cells primarily
express two PRC1 complexes containing either Cbx7 or RYBP
[7]. Whereas Cbx7-PRC1 mediates early repression of differen-
tiation genes by binding to H3K27me3, RYBP-PRC1 binds
independently of the methylation status of H3K27 and is
associated with lower levels of Ring1b and H2A ubiquitination
and occupies genes that are less repressed [29]. Cbx7 and Cbx8
are expressed in an almost mutually exclusive manner in self-
renewing and differentiating ES cells, respectively. Although in
vitro the chromodomain of Cbx7 has higher affinity to
H3K27me3 than the one of Cbx8 [30], in cells we found that
both proteins were able to efficiently replace each other on genes.
Enforced expression of Cbx7 in differentiating cells was able to
compete with Cbx8 for its target genes and to reduce gene
activation. In the converse experiment similarly efficient replace-
ment of Cbx7 by exogenous Cbx8 in self-renewing ES cells was
not sufficient to induce derepression (Fig. 8A–D). These results
place Cbx7 over Cbx8 in the functional hierarchy of Polycomb
proteins. Future studies will have to assess in greater detail how
different PRC1 complexes regulate cell fate decisions. Our
preliminary data shows that ES cells that maintain 30–50%
reduced Cbx8 expression are qualitatively able to differentiate into
Fig. 8. The exchange of Cbx7 for Cbx8 is required but not sufficient to promote the differentiation of mES cells. (A-D) Parental ES cells
treated with RA for three days or left untreated were compared to untreated ES cells expressing exogenous Cbx8 and differentiating ES treated with
RA for three days and expressing exogenous Cbx7. Consistent color coding of cells and treatments is as indicated in A. (A) The expression levels of
endogenous and exogenous epitope (e)-tagged Cbx proteins is shown by Western blot of lysates from stable transfected ES cells (e-Cbx7 and e-Cbx8,
respectively) and parental control cells. Exogenous and endogenous protein bands are marked by one or two asterisks, respectively. Cells were
treated with RA for three days as indicated. Histone H3 was used as loading control. (B) The occupancy of Cbx7 and Cbx8 on selected genes was
analyzed by ChIP in untreated ES cells overexpressing Cbx8 (red bars) and parental control cells treated with RA for three days (black bars) or left
untreated (grey bars). ChIP-Input ratios for each gene and antibody are shown relative to the maximal enrichment. IgG is shown relative to Cbx8 ChIP.
Error bars denote s.d.; n = 3; * = p,0.05. (C) Relative mRNA levels of the same genes as in B measured by qRT-PCR are shown. Error bars denote s.d.;
n = 3; * = p,0.05; n.s. = not significant. (D) ChIP of Cbx8 or Cbx7 in Cbx7-overexpressing cells treated with RA for three days (blue bars) and control
cells treated with RA (black bars) or left untreated (grey bars). ChIP-Input ratios for each gene and antibody are shown relative to the maximal
enrichment. IgG is shown relative to Cbx8 ChIP. Error bars denote s.d.; n = 3; * = p,0.05. (E) Cartoon illustrating our finding that Cbx8-containing PRC1
complexes replace Cbx7-containing PRC1 complexes during the initial activation of differentiation genes. During a metastable transition state
binding of Cbx8-containing PRC1 co-occurs with the presence of both repressive marks such as H3K27me3 and active marks such as H3K36me3.
Prolonged activation results in loss of Cbx8-containing PRC1 that precedes the removal of H3K27me3.
doi:10.1371/journal.pgen.1004851.g008
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Tuj1-positive neurons with neurite outgrowth following 11 days of
a long-term differentiation protocol (adapted from [31]), but seem
to do so in a less efficient way (S6 Figure).
Polycomb proteins and gene activation
The number of observations linking Polycomb proteins and
active gene transcription are increasing. Here we report that the
transient recruitment of PRC1 containing Cbx8 facilitates the
transition from a Polycomb-repressed to a fully active state of key
regulatory genes during early differentiation. Others have
suggested that binding of Cbx8 to active genes could mark these
for later repression [19]. Our data does not support this as we find
Cbx8 recruitment to be only transient and all PRC1 to be entirely
evicted after prolonged gene activation (Fig. 5).
It is worth to point out that Cbx8 target genes that got repressed
after treatment with retinoic acid were not affected by the
knockdown of Cbx8. This can be explained by a possible
compensation by other canonical repressing PRC1 complexes or
a recent finding showing that Polycomb protein recruitment is
rather a consequence than a cause of initial gene silencing [32].
Studying differentiating myocytes, others have reported that
Ezh1 associates with actively transcribed genes and further argued
for a positive function in which Ezh1 could be required for the
recruitment of Polymerase II [33]. In contrast, Pombo and
colleagues suggested that their observed Polycomb-binding to
transcribed metabolic genes was the consequence of a continuous
switching between an active and a Polycomb-repressed state
restraining transcriptional elongation [34]. In Drosophila cells,
PRC1 was found to indirectly associate with some active as well as
inactive genes by binding to structural cohesin proteins [35]. The
authors argued again for a more active role on active genes by
suggesting that PRC1 could be required for allowing the
phosphorylation that makes Polymerase II elongation competent.
A large body of additional work is needed to sort out the relation
between Polycomb-bound and transcribed chromatin states in
greater detail. In this endeavor it will be important to carefully
distinguish between passive contributions from reductions in




We produced a specific polyclonal antibody against mouse
Cbx8 by immunizing rabbits with a His-tagged fragment of Cbx8
protein encompassing amino acids 201–360. Serum was pre-
cleared with sepharose and passed over a column containing a
fusion protein of glutathione-S-transferase (GST) and amino acids
201–360 of Cbx8 covalently cross-linked to Glutathione sephar-
ose. Anti-Cbx8 antibody was eluated with low pH, dialyzed and
stored in PBS with 20% glycerol. The antibody performed in a
similar way to antibodies previously described and kindly provided
by Kristian Helin [13]; (S1 Figure). In addition we made use of the
following antibodies: anti-IgG (Abcam), anti-H3 C-terminal
(Abcam) and anti-H3K27me3 (Millipore), anti-Flag M2 (Sigma-
Aldrich), anti-Ring1b provided by Luciano Di Croce [36], anti-
H3K27Ac and anti-Cbx7 (Abcam), anti-H3K36me3 (Abcam) and
rabbit monoclonal anti-ubiquityl-H2A (Lys119, D27C4, Cell
Signaling Technology). The amounts and concentrations used
for ChIP and western blotting is given in S3 Table. Expression
plasmids and pLKO-1 constructs for shRNA-mediated knock-
down were generated with standard PCR and cloning techniques.
For stable expression in ES cells, cDNAs were cloned in frame
with a multiple-epitope tag into a vector containing CAG
promoter and an IRES-puromycin resistance gene cassette [37].
A modified and gateway cloning-adapted (Life Technologies)
version was kindly provided by Diego Pasini.
Cell culture, gene transduction and cell differentiation
E14Tg2A.4 mouse ES cells were cultured as previously
described [38]. Cells were transduced with lentiviral shRNA
cassettes essentially as described before [39]. Transduced cells
were selected with 2 mg/ml puromycin. For shRNA sequences see
S3 Table. For the generation of stably expressing ES cell clones,
the above described CAG promoter driven vectors were trans-
fected into mouse ES cells E14 using Lipofectamine 2000 (Life
Technologies). Stable transfectants were selected with 2 mg/ml
puromycin and analyzed by RT-PCR and western blot for
transgene expression. For neuronal differentiation, 1 mM all trans
retinoic acid (RA) was added directly to cells in medium without
leukemia inhibitory factor. Unless indicated otherwise in Figure
legends, cells were collected after 3 days of RA treatment.
Protein and RNA analysis
Lysis and western blot analyses were performed as previously
described [40]. Following the supplier’s instructions, RNA was
purified from 26106 cells using the RNeasy minikit (Qiagen), with
a DNase I digestion step to avoid any potential DNA contami-
nation. Total RNA (1 mg) was reverse transcribed using a cDNA
synthesis kit (Roche Diagnostics) and oligo(dT) primers. Relative
cDNA levels were quantified by quantitative PCR (qRT-PCR).
Values were normalized to the expression of two housekeeping
genes (Rpo and Gapdh). For gene expression analysis, four
biological replicates of RA treated (3 days) and untreated ES cells
were used for each condition and samples were prepared and
hybridized to SurePrint G3 Mouse GE 8660K Microarrays
(Agilent technologies) following the supplier’s instructions. Anal-
yses were essentially performed as described [41] selecting
differentially expressed probes with a FDR of 0.05 and fold
change of .1.5.
ChIP and ChIP-seq
Chromatin fragmented to a size ranging from 300–500 bps and
immunoprecipitation (ChIP) experiments were performed essen-
tially as previously described [42]. ChIP-reChIP experiment was
performed as described elsewhere [34]. The sequences of all
oligonucleotides used here are provided in the S3 Table. Unless
indicated otherwise, ChIP results are given as the percentage of
the amount of ChIP-enriched DNA relative to the amount of
DNA isolated from one tenth of input material measured by
quantitative PCR. For ChIP-sequencing (ChIP-seq), 10 ng of
DNA was enriched by ChIP and fluorimetrically quantified with
PicoGreen. Library generation and direct massive parallel
sequencing on an Illumina genome analyzer were performed
according to the supplier’s instructions. Reads obtained were
cleaned based on quality, trimmed using the ShortRead package
in R [43] and aligned with the mouse genome (NCBIM37/mm9)
using Bowtie version 0.12.7 [44], two mismatches were allowed for
the alignment within the seed, only reads mapping to a single
position in the genome were used. To detect genomic regions with
significant enrichment we used MACS software version 1.4.1 [45].
For peak calling of Cbx8 in RA-treated ES cells we used a p-value
cut-off of 161024 and a FDR of 5%. Both IgG and Cbx8 from
self-renewing cells (that do not express Cbx8) were independently
used as control libraries. Only peaks called in both cases (minimal
overlap of 50 bps) were accepted as high confidence target peaks
and further analyzed. A subset was validated by direct ChIP.
Peaks were annotated using ChIPpeakAnno package [46]. Genes
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were considered to be target genes if the center of a peak was
found in the transcribed region 63 kb using the transcript set of
Mouse Ensembl Gene (based on assembly NCBIM37/mm9). In
cases where a peak annotated to two genes, the nearest gene was
selected and identified by the minimal distance between peak
center and transcribed region. Un ambiguous peak that was
found inside an intron of three differently annotated transcripts
(chr10:3310058,3311329) was excluded from the analysis. To
calculate the normalized enrichment profile we have used
ngs.plot ver 2.0 [47]. The gene ontology analysis was performed
using the function ‘‘getEnrichedGO’’ from ChippeakAnno
package, we used the Ensembl gene ID and accepted GO
categories with an adjusted P-value of 0.001 or less. P-values were
calculated using the multiple adjusted Benjamini-Hochberg
method. A value of ten was set as minimum count in the
genome for a GO term to be included. For visualizing GO
categories we used REVIGO [48], using the following param-
eters: ‘‘Medium’’ for the allowed similarity and ‘‘SimRel’’ for
semantic similarity measure. Gene ontologies were grouped and
genes were scored if they were associated to one or more ontology
terms per group.
Proteomic analysis
For proteomic analysis, 26108 differentiated ES cells expressing
Flag-epitope tagged Cbx8 and parental control cells were collected
with PBS. Nuclei were isolated using sucrose buffer and nuclear
extract was separated from chromatinic fraction by a high salt
extraction protocol followed by ultracentrifugation (1 h
50000 rpm). The soluble fraction containing nuclear extract was
diluted to isotonic concentration followed by a preclear step using
sepharose beads. Binding to Anti-Flag M2 Beads (Sigma-Aldrich)
was performed in a rotating wheel during 2 h. Then, Anti-Flag
M2 Beads were passed into a column for further enrichment and
washing steps. Beads were collected into tubes for elution with
50 mM NaHCO3 and 0, 5% SDS. Eluated proteins were
precipitated with cold acetone and frozen dry pellets were sent
to a Proteomics facility for mass spectrometry analysis. Samples
were digested with trypsin and 1 mg of each sample was injected in
an Orbitrap Velos to LC-MS/MS analysis. Data was searched
using an internal version of the search algorithm Mascot against a
SwissProt_Mouse database (July 2013). Protein identification and
peptides identified for each protein were identified using Proteome
Discoverer v1.4, which gives an approximate estimation of protein
amount with the average peak area of the 3 top peptides for a
given protein. The number of peptides identified for each protein
is a parameter of quality, the more peptides the better. Peptides
were filtered based on the 1%FDR. Only proteins enriched more
than 10 fold and with a coverage of at least 5% were considered
for analysis.
Statistics
Unless indicated otherwise, qRT-PCR and ChIP data is
represented as the mean of three independent experiments and
errors denote the standard deviation and stars indicate p-values
below 0.05 as determined by the two-tailed Student’s T-tests.
Individual ChIP experiments are normalized to the average
enrichment observed in the experiment. Means and errors of
three experiments are scaled to represent the average of all
experiments.
Accession numbers
ChIP-seq and Microarray data have been deposited in the GEO
database under accession number GSE54053.
Supporting Information
S1 Figure Cbx8 induction during differentiation and generation
of a specific Cbx8 antibody. (A) The relative mRNA levels of Cbx
protein-encoding genes analyzed by qRT-PCR. Oct4 and Nanog
were included as differentiation controls. Values from untreated
cells were set to 1 and are plotted on a linear scale. (B) Schematic
representation of the human CBX8 protein. Domain structure is
according to Senthilkumar and Mishra [9]. The maximal
sequence identity to other proteins is indicated for a 50 amino
acid sliding window using the information provided by the human
protein atlas project (www.proteinatlas.org). A stretch with
minimal intraspecies identity to unrelated proteins and maximal
conservation between mouse and human (.90% identity) was
used as His-tagged antigen. (C) Scheme of the affinity purification
of the antibody. Serum from immunized rabbits is precleared with
sepharose and passed over a column containing a fusion protein of
glutathione-S-transferase (GST) and amino acids 201–360 of
CBX8 covalently cross (X)-linked to Glutathione sepharose. Anti-
CBX8 antibody is eluated with low pH and stored in PBS with
20% glycerol. (D) Total cell lysates of NTera2/D1 (NT2) cells
stably expressing shRNAs for CBX8 and controls were analyzed
by western blot using the anti-CBX8 antibody. Anti- macroH2A1
antibody was used to control loading. (E) HEK293T cells were
transiently transfected with HA-tagged CBX8 expression vector.
Immunoprecipitations were performed under regular and chro-
matin immunoprecipitation (ChIP) conditions (crosslinking, strin-
gent washing). As shown by western blot analysis using anti-HA
antibody 5 mg anti-Cbx8 antibody performed well under both
conditions. (F) Finally, we compared the performance of our anti-
Cbx8 antibody (MB) to two well described antibodies that were
kindly provided by Kristian Helin [13]. 5 mg of each antibody was
used and IgG as control. As shown on 3 target genes in ES cells
treated for three days with retinoic acid (RA), all three antibodies
enriched similarly well. (G) Specificity of the ChIP signal is shown
by the loss of signal in cells that have been infected with retroviral
shRNA vectors specific for Cbx8 or controls.
(TIF)
S2 Figure Mapped reads and peak selection. Related to Fig. 1.
(A) Details on the ChIP-seq data sets deposited in GEO. (B)
Scheme for the identification of the subset of high confidence
binding sites. We used MACS algorithm to identify peaks in the
ES.Cbx8.RA library by comparing it independently to two control
libraries, ES.IgG and ES.Cbx8.untreated. Overlapping peaks
(min. 50 bp) are considered to represent 171 high confidence
binding sites that have been analyzed further.
(TIF)
S3 Figure Gene ontologies and overlap with Ring1b and
H3K27me3. (A) Bar graphs showing up to 30 top gene ontologies
terms ordered for the –log10 adjusted p-value #0.001. Plots are
shown for all genes annotated to Cbx8 peaks and also separately
for up-, down- or not regulated genes considering a minimal fold-
change of 1.2 comparing untreated and RA-treated cells. (B) Venn
diagrams showing the overlap of Cbx8 target genes in RA-treated
cells with those of Ring1b and H3K27me3 in untreated ES cells.
(TIF)
S4 Figure Influence of shRNA-mediated knockdown of Cbx8 or
Ring1b on other PRC1 components and Cbx8 target genes.
Related to Fig. 5. (A) FLAG-epitope tagged Cbx8 is detected in
untreated ES cells binds to the same target genes as endogenous
Cbx8 in RA-treated cells. ChIP data is shown. Error bars denote
the variation of the mean of two independent experiments. (B)
Knockdown of Cbx8 does not affect global Ring1b levels. Control
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and Cbx8-specific shRNA expressing cells were treated with RA
for 3 days or left untreated. Lysates were analyzed by
immunoblotting. (C) Repression of Cbx8 is not compensated by
upregulation of Cbx2, Cbx4 or Cbx7. qRT-PCR analysis of
mRNA levels in the same cells as A treated with RA for three days.
Error bars denote s.d.; n = 3. (D) Control cells and cells expressing
two different Ring1b-specific shRNAs were analyzed after three
days of RA treatment. RNA was analyzed by qRT-PCR. Error
bars denote s.d.; n = 3.
(TIF)
S5 Figure Low but detectable H3K27ac is sensitive to loss of
Cbx8 in RA-treated ES cells. Related to Fig. 7. All experiments
have been performed with ES cells treated with RA for three days,
which is the time point of maximal Cbx8 recruitment (Fig. 5). (A)
The H3K27ac observed by ChIP on Cbx8 target genes Sox9 and
Tbx18 (average is plotted) is low compared to an enhancer with
well known H3K27ac enrichment (Seq1 from [49]). (B) Histone
H3K27ac levels on 4 Cbx8 target genes have been analyzed in
control cells and in cells with shRNA-mediated knockdown of
Cbx8. For each gene ChIP to input ratios of both are shown
relative to the value from control cells expressing sh Scr. Error bars
denote s.d.; n = 3; *, p,0.05. (compared to control cells).(C)
Antibodies have been titrated by ChIP to precipitate similar levels
of target gene DNA (left panel). Same amounts of antibodies were
used to reChIP from anti-Cbx8 ChIP-enriched chromatin. Error
bars represent the variation of the mean of two independent
experiments.
(TIF)
S6 Figure Neuronal differentiation of ES cells with reduced
Cbx8 expression. (A) Control and Cbx8 knockdown cells were
plated onto bacteriological Greiner Petri dishes in 15 ml of EB
medium in order to form embryoid bodies (EBs). Medium of EBs
has been changed after 2 days. Another two days later, medium
has been changed again and retinoic acid (RA) has been added.
Another two days later, medium has been changed again with
fresh medium containing RA. After 8 days of differentiation, the
EBs have been dissociated using trypsin and plated in N2B27
medium onto polyornithine and laminin-coated plates. RNA was
extracted at day 11 of the differentiation protocol and analyzed by
qRT-PCR. Data is the mean of values obtained for two
independent hairpins and is presented in respect to the value
from control cells that has been set to 1. Error bars indicate the
range of the individual values. (B) The same cells as in A were
analyzed by immunofluorescence using antibody against the
neuronal marker Tuj1.
(TIF)
S1 Table ChIP-seq peaks, annotated genes and their expression
change after RA treatment. The table contains the data that was
used to generate the Fig. 1D–F.
(XLSX)
S2 Table Proteomics data. Cbx8 and interacting proteins were
enriched by affinity purification and analyzed by mass spectrom-
etry and significantly enriched proteins were ranked according to
their abundance. The table contains the list of results from which
the table in Fig. 4B has been extracted.
(PDF)
S3 Table Oligo sequences and antibodies. The sequences of all
oligos and their position is given. For antibodies we detail sources
and amounts used for ChIP, IP and immunoblotting, respectively.
(XLSX)
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